194 related articles for article (PubMed ID: 31791289)
21. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of arachidonic acid by rat adrenal glomerulosa cells: synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids.
Campbell WB; Brady MT; Rosolowsky LJ; Falck JR
Endocrinology; 1991 Apr; 128(4):2183-94. PubMed ID: 1900788
[TBL] [Abstract][Full Text] [Related]
23. A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue.
Yue H; Jansen SA; Strauss KI; Borenstein MR; Barbe MF; Rossi LJ; Murphy E
J Pharm Biomed Anal; 2007 Feb; 43(3):1122-34. PubMed ID: 17125954
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
26. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
27. Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.
Chung AS; Kowanetz M; Wu X; Zhuang G; Ngu H; Finkle D; Komuves L; Peale F; Ferrara N
J Pathol; 2012 Aug; 227(4):404-16. PubMed ID: 22611017
[TBL] [Abstract][Full Text] [Related]
28. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
Gately S; Kerbel R
Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome 450 metabolites of arachidonic acid (20-HETE, 11,12-EET and 14,15-EET) promote pheochromocytoma cell growth and tumor associated angiogenesis.
Colombero C; Cárdenas S; Venara M; Martin A; Pennisi P; Barontini M; Nowicki S
Biochimie; 2020; 171-172():147-157. PubMed ID: 32105813
[TBL] [Abstract][Full Text] [Related]
31. Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes.
Kimura R; Takahashi N; Murota K; Yamada Y; Niiya S; Kanzaki N; Murakami Y; Moriyama T; Goto T; Kawada T
Biochem Biophys Res Commun; 2011 Jun; 410(1):1-6. PubMed ID: 21640707
[TBL] [Abstract][Full Text] [Related]
32. 20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma.
Fang X; Dillon JS; Hu S; Harmon SD; Yao J; Anjaiah S; Falck JR; Spector AA
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):175-84. PubMed ID: 17164145
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans.
Gangadhariah MH; Dieckmann BW; Lantier L; Kang L; Wasserman DH; Chiusa M; Caskey CF; Dickerson J; Luo P; Gamboa JL; Capdevila JH; Imig JD; Yu C; Pozzi A; Luther JM
Diabetologia; 2017 Jun; 60(6):1066-1075. PubMed ID: 28352940
[TBL] [Abstract][Full Text] [Related]
34. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.
Nakagawa K; Sasaki Y; Kato S; Kubodera N; Okano T
Carcinogenesis; 2005 Jun; 26(6):1044-54. PubMed ID: 15718253
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferation activation receptor alpha modulation of Ca2+-regulated exocytosis via arachidonic acid in guinea-pig antral mucous cells.
Sawabe Y; Shimamoto C; Sakai A; Kuwabara H; Saad AH; Nakano T; Takitani K; Tamai H; Mori H; Marunaka Y; Nakahari T
Exp Physiol; 2010 Aug; 95(8):858-68. PubMed ID: 20472647
[TBL] [Abstract][Full Text] [Related]
36. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
Kohno H; Suzuki R; Sugie S; Tanaka T
BMC Cancer; 2005 May; 5():46. PubMed ID: 15892897
[TBL] [Abstract][Full Text] [Related]
37. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
[TBL] [Abstract][Full Text] [Related]
38. Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment.
Poczobutt JM; Gijon M; Amin J; Hanson D; Li H; Walker D; Weiser-Evans M; Lu X; Murphy RC; Nemenoff RA
PLoS One; 2013; 8(11):e79633. PubMed ID: 24244531
[TBL] [Abstract][Full Text] [Related]
39. Enhancement role of host 12/15-lipoxygenase in melanoma progression.
Kang KH; Ling TY; Liou HH; Huang YK; Hour MJ; Liou HC; Fu WM
Eur J Cancer; 2013 Aug; 49(12):2747-59. PubMed ID: 23664097
[TBL] [Abstract][Full Text] [Related]
40. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
